Signals mentioning PharmEasy
- Reliance Retail buys 60% of NetMeds parent Vitalic Health for ₹620 crore
- Reliance Retail buys 60% of NetMeds parent Vitalic Health for ₹620 crore
- Reliance Retail buys 60% of NetMeds parent for ₹620 crore, enters e-pharmacy
- Reliance Retail buys 60% of NetMeds parent Vitalic Health for ₹620 crore
- Reliance Retail buys 60% of NetMeds parent Vitalic Health for ₹620 crore
- Reliance Retail buys 60% of NetMeds parent Vitalic Health for ₹620 crore
- Nilekani's Fundamentum launches Rs 2,200 crore Fund III to back consumer-tech and fintech
- Nilekani's Fundamentum launches Rs 2,200 crore Fund III for consumer-tech and fintech
- Fundamentum launches ₹2,200 crore third fund for Series B consumer-tech and retail startups
- Fundamentum launches Rs 2,200 Cr Fund III to back Series B consumer-tech and commerce startups
- The Func. Lab raises $1.5M seed to scale clean-label nutrition across D2C and retail
- PharmEasy founders' All Home raises Rs 200 cr at doubled Rs 2,000 cr valuation
- AllHome bags ₹200 cr Series B at ₹2,000 cr valuation to scale building materials play
- AllHome raises ₹200 Cr Series B at $210 Mn valuation to scale interiors house-of-brands
- AllHome raises Rs 200 Cr Series B at Rs 2,000 Cr valuation, led by Bessemer
- AllHome raises Rs 200 Cr Series B at Rs 2,000 Cr valuation, led by Bessemer
- Nilekani-backed Fundamentum targets Rs 1,800-2,500 cr Fund III for growth-stage consumer bets
- Chemists strike against e-pharmacies as 2018 rules lapse, leaving PharmEasy in regulatory limbo
- PharmEasy parent API Holdings pulls IPO, pivots to rights issue for growth funding
- PharmEasy parent API Holdings pulls Rs 6,250 cr IPO, weighs rights issue from Prosus, TPG, Temasek